Literature DB >> 1862342

Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase.

D R Knighton1, J H Zheng, L F Ten Eyck, V A Ashford, N H Xuong, S S Taylor, J M Sowadski.   

Abstract

The crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase complexed with a 20-amino acid substrate analog inhibitor has been solved and partially refined at 2.7 A resolution to an R factor of 0.212. The magnesium adenosine triphosphate (MgATP) binding site was located by difference Fourier synthesis. The enzyme structure is bilobal with a deep cleft between the lobes. The cleft is filled by MgATP and a portion of the inhibitor peptide. The smaller lobe, consisting mostly of amino-terminal sequence, is associated with nucleotide binding, and its largely antiparallel beta sheet architecture constitutes an unusual nucleotide binding motif. The larger lobe is dominated by helical structure with a single beta sheet at the domain interface. This lobe is primarily involved in peptide binding and catalysis. Residues 40 through 280 constitute a conserved catalytic core that is shared by more than 100 protein kinases. Most of the invariant amino acids in this conserved catalytic core are clustered at the sites of nucleotide binding and catalysis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1862342     DOI: 10.1126/science.1862342

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  465 in total

1.  The tRNA-binding moiety in GCN2 contains a dimerization domain that interacts with the kinase domain and is required for tRNA binding and kinase activation.

Authors:  H Qiu; J Dong; C Hu; C S Francklyn; A G Hinnebusch
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

2.  Three dimensional atomic model and experimental validation for the ATP-Regulated Module (ARM) of the atrial natriuretic factor receptor guanylate cyclase.

Authors:  T Duda; P Yadav; A Jankowska; V Venkataraman; R K Sharma
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

3.  Functional analysis of H-Ryk, an atypical member of the receptor tyrosine kinase family.

Authors:  R M Katso; R B Russell; T S Ganesan
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

Review 4.  Multiple pathways control protein kinase C phosphorylation.

Authors:  D B Parekh; W Ziegler; P J Parker
Journal:  EMBO J       Date:  2000-02-15       Impact factor: 11.598

5.  Three dimensional atomic model and experimental validation for the ATP-Regulated Module (ARM) of the atrial natriuretic factor receptor guanylate cyclase.

Authors:  T Duda; P Yadav; A Jankowska; V Venkataraman; R K Sharma
Journal:  Mol Cell Biochem       Date:  2000-11       Impact factor: 3.396

Review 6.  Mitogen-activated protein kinases: specific messages from ubiquitous messengers.

Authors:  H J Schaeffer; M J Weber
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

7.  Mutations that bypass tRNA binding activate the intrinsically defective kinase domain in GCN2.

Authors:  Hongfang Qiu; Cuihua Hu; Jinsheng Dong; Alan G Hinnebusch
Journal:  Genes Dev       Date:  2002-05-15       Impact factor: 11.361

8.  Two-dimensional crystal structures of protein kinase C-delta, its regulatory domain, and the enzyme complexed with myelin basic protein.

Authors:  Alexander S Solodukhin; Heather L Caldwell; Julianne J Sando; Robert H Kretsinger
Journal:  Biophys J       Date:  2002-05       Impact factor: 4.033

9.  The crystal structure of the Physarum polycephalum actin-fragmin kinase: an atypical protein kinase with a specialized substrate-binding domain.

Authors:  S Steinbacher; P Hof; L Eichinger; M Schleicher; J Gettemans; J Vandekerckhove; R Huber; J Benz
Journal:  EMBO J       Date:  1999-06-01       Impact factor: 11.598

10.  PKA/PrKX activity is a modulator of AAV/adenovirus interaction.

Authors:  Giovanni Di Pasquale; John A Chiorini
Journal:  EMBO J       Date:  2003-04-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.